How to Build This Generation's Big Pharma Company

Episode 128

0:00-41:04

Drug discovery has doubled the flow of candidates, but approvals remain roughly flat. The constraint is development, not discovery. In this episode, a16z General Partner, Jorge Conde talks with Formation Bio cofounder and CEO Ben Liu about building a modern pharma company around clinical execution. They discuss Formation Bio’s hub-and-spoke model for acquiring and advancing assets, how AI compresses trial timelines and costs, picking winners, regulatory strategy, and what it would take to move from about 50 approvals a year to many more. They also touch on global competition and why clinical proof still drives value in...

Publisher

Raising Health

Link

raisinghealth.simplecast.com/episodes/formation-bio-halving-the-cost-and-time-of-clinical-trials-with-ai-r96XS9Vy

Published

November 17, 2025

Duration

41 min

Format

Podcast

Category

Issues · Science

Source

RSS feed

Host

Andreessen Horowitz, a16z Bio + Health

RH

Raising Health

@raisinghealth

#build #generationsbigpharma #lifesciences

The Nile